| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6842
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6818 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2012-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2012-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120125157-A |
| titleOfInvention |
How to diagnose cancer with lectins |
| abstract |
The present invention relates to a method for diagnosing cancer using information on abnormal aberrant glycosylation of glycoproteins related to cancer progression, and more particularly, abnormally glycated glycoproteins according to cancer development and progression. Isolating the lectin using a lectin and selecting and quantifying a marker peptide generated from hydrolysis of the glycoprotein separated by the lectin, thereby diagnosing a cancer using the peptide marker for diagnosis of cancer and the peptide marker. It is about how to. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101520614-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9938561-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015093800-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015023068-A1 |
| priorityDate |
2011-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |